Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

Control of pain initiation by endogenous cannabinoids

Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,055 · see citing works

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · see citing works

Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners

Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 800 · see citing works

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785 · see citing works

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor

Hanuš, L., Abu‐Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I. M., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 761 · see citing works

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752 · see citing works

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · see citing works

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 688 · see citing works

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679 · see citing works

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669 · see citing works

Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a GsLinkage to the CB1 Receptor

Glass, M., & Felder, C. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 634 · see citing works

Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor

Porter, A. C., Sauer, J., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P. A., Bymaster, F. P., Leese, A. B., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 614 · see citing works

Cannabinoid physiology and pharmacology: 30 years of progress

Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608 · see citing works

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 598 · see citing works

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589 · see citing works

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Baker, D., Pryce, G., Croxford, J., Brown, P., Pertwee, R., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 546 · see citing works

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 537 · see citing works

The cannabinoid system and immune modulation

Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 524 · see citing works

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

Handbook of experimental pharmacology

(1971) · American Heart Journal · doi:10.1016/0002-8703(71)90220-1 · Cited by 472 · see citing works

Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension

Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410 · see citing works

Endocannabinoids control spasticity in a multiple sclerosis model

Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A. D., Layward, L., Fezza, F., Bisogno, T., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0399fje · Cited by 378 · see citing works

Cannabinoid‐receptor expression in human leukocytes

Bouaboula, M., Rinaldi, M. L., CARAYON, P., Carillon, C., Delpech, B., Shire, D. J., Fur, G. L., & Casellas, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 367 · see citing works

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 346 · see citing works

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

Carlisle, S. J., Marciano‐Cabral, F., Staab, A., LUDWICK, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344 · see citing works

The therapeutic potential of cannabis

Baker, D., Pryce, G., Giovannoni, G., & Thompson, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00381-8 · Cited by 344 · see citing works

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant

Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337 · see citing works

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336 · see citing works

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314 · see citing works

The fatty acid amide hydrolase (FAAH)

Ueda, N., Puffenbarger, R. A., Yamamoto, S., & Deutsch, D. G. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00190-0 · Cited by 256 · see citing works

Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.

Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253 · see citing works

Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

Zhu, L. X., Sharma, S. P., Stolina, M., Gardner, B. K., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 250 · see citing works

Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 248 · see citing works

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

BRADY, C. M., Dasgupta, R., Dalton, C. M., Wiseman, O. J., Berkley, K. J., & Fowler, C. J. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1063oa · Cited by 240 · see citing works

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms1048oa · Cited by 239 · see citing works

Cannabinoid receptors and immunity

Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235 · see citing works

Cannabinoids and brain injury: therapeutic implications

Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229 · see citing works

Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor

Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 227 · see citing works

The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells

Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 223 · see citing works

Biology of Naegleria spp

Marciano‐Cabral, F. (1988) · Microbiological Reviews · doi:10.1128/mr.52.1.114-133.1988 · Cited by 223 · see citing works

The fatty acid amide hydrolase (FAAH)

Deutsch, D. G., Ueda, N., & Yamamoto, S. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0358 · Cited by 209 · see citing works

Advances in Experimental Medicine and Biology

Dombovy, M. L. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540240021005 · Cited by 207 · see citing works

Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90075-1 · Cited by 200 · see citing works

Enzymatic Synthesis of Anandamide, an Endogenous Cannabinoid Receptor Ligand, through N-Acylphosphatidylethanolamine Pathway in Testis: Involvement of Ca2+-Dependent Transacylase and Phosphodiesterase Activities

Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 195 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17652 · Cited by 195 · see citing works

Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia

Molina‐Holgado, F., Pinteaux, E., Moore, J. D., Molina‐Holgado, E., Guaza, C., Gibson, R. M., & Rothwell, N. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06470.2003 · Cited by 192 · see citing works

Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase

Rhee, M. H., Vogel, Z., Barg, J., Bayewitch, M. L., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 192 · see citing works

Marijuana, immunity and infection

Klein, T., Friedman, H., & Specter, S. C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00226-9 · Cited by 192 · see citing works

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.

Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190 · see citing works

Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

Srivastava, M. D., Srivastava, B. I. S., & Brouhard, B. H. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00041-1 · Cited by 189 · see citing works

Pro-inflammatory cytokines induce the transcription factors C/EBP? and C/EBP? in astrocytes

Cardinaux, J., Allaman, I., & Magistretti, P. J. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1 · Cited by 183 · see citing works

Cannabinoids and multiple sclerosis

Pertwee, R. G. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00255-3 · Cited by 181 · see citing works

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

Schwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 181 · see citing works

Modulation and Functional Involvement of CB2 Peripheral Cannabinoid Receptors During B-Cell Differentiation

Carayon, P., Marchand, J., Dussossoy, D., Derocq, J., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 178 · see citing works

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors

Wagner, J. A., Járai, Z., Bátkai, S., & Kunos, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01112-8 · Cited by 177 · see citing works

Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil againstIn VivoExcitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases

Veldhuis, W. B., van der Stelt, M., Wadman, M. W., van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G. A., Vliegenthart, J. F. G., Bär, P. R., Nicolay, K., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04127.2003 · Cited by 175 · see citing works

Cannabinoids and glaucoma

Tomida, I. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.032250 · Cited by 172 · see citing works

Effects of Cannabinoid Receptor Agonist and Antagonist Ligands on Production of Inflammatory Cytokines and Anti-Inflammatory Interleukin-10 in Endotoxemic Mice

Smith, S. R., Terminelli, C., & Denhardt, G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39213-4 · Cited by 170 · see citing works

Cannabinoids enhance human B‐cell growth at low nanomolar concentrations

Derocq, J., Ségui, M., Marchand, J., Fur, G. L., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 167 · see citing works

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 167 · see citing works

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163 · see citing works

Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial*

Knoller, N., Levi, L., Shoshan, I., Reichenthal, E., Razon, N., Rappaport, Z. H., & Biegon, A. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00009 · Cited by 161 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317652 · Cited by 160 · see citing works

Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection

Klein, T., Newton, C. A., Nakachi, N., & Friedman, H. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6461 · Cited by 159 · see citing works

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

Alberich-Jordà, M., Verbakel, S. E., Valk, P. J. M., Vankan, Y., Maccarrone, M., Finazzi-Agrò, A., Löwenberg, B., & Delwel, R. (2002) · Blood · doi:10.1182/blood.v99.8.2786 · Cited by 158 · see citing works

Progesterone Up-Regulates Anandamide Hydrolase in Human Lymphocytes: Role of Cytokines and Implications for Fertility

Maccarrone, M., Valensise, H. C. C., Bari, M., Lazzarin, N., Romaninï, C., & Finazzi‐Agrò, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7183 · Cited by 152 · see citing works

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease

Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151 · see citing works

Further evidence for the existence of a specific process for the membrane transport of anandamide

Ligresti, A., Morera, E., van der Stelt, M., Monory, K., Lutz, B., Ortar, G., & Marzo, V. D. (2004) · Biochemical Journal · doi:10.1042/bj20031812 · Cited by 144 · see citing works

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 137 · see citing works

Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2

Condie, R. B., Herring, A. C., Koh, W. S., Lee, M., & Kaminski, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13175 · Cited by 135 · see citing works

Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism

Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 133 · see citing works

Simultaneous Measurement of Anandamide and 2-Arachidonoylglycerol by Polymyxin B-Selective Adsorption and Subsequent High-Performance Liquid Chromatography Analysis: Increase in Endogenous Cannabinoids in the Sera of Patients with Endotoxic Shock

Wang, Y., Liu, Y., Ito, Y., Hashiguchi, T., Kitajima, I., Yamakuchi, M., Shimizu, H., Matsuo, S., Imaizumi, H., & Maruyama, I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5015 · Cited by 129 · see citing works

Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid

Liu, J., Li, H., Burstein, S. H., Zurier, R. B., & Chen, J. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.983 · Cited by 129 · see citing works

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN

Filippo, C. D., Rossi, F., Rossi, S., & D’Amico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 128 · see citing works

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Sacerdote, P., Massi, P., Panerai, A. E., & Parolaro, D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00307-6 · Cited by 124 · see citing works

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., & Sugiura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301359200 · Cited by 122 · see citing works

Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus

Morahan, P. S., Klykken, P. C., Smith, S., Harris, L. S., & Munson, A. E. (1979) · Infection and Immunity · doi:10.1128/iai.23.3.670-674.1979 · Cited by 121 · see citing works

Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A

Welch, S. P., Huffman, J. W., & Lowe, J. A., III (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37725-0 · Cited by 120 · see citing works

Suppression of experimetal autoimmune encephalomyelitis by cannabinoids

Wirguin, I., Mechoulam, R., Breuer, A., Schezen, E., Weidenfeld, J., & Brenner, T. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90056-6 · Cited by 117 · see citing works

Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation

McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 115 · see citing works

Cardiovascular actions of cannabinoids and their generation during shock

Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 111 · see citing works

Cannabinoids and Multiple Sclerosis

Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 110 · see citing works

Effects on the Immune System

Cabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 108 · see citing works

The endogenous cannabinoid anandamide potentiates interleukin‐6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor‐mediated pathway

Molina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 108 · see citing works

Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells

Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 103 · see citing works

The Effect of Delta-9-Tetrahydrocannabinol and 11-Hydroxy-Delta-9-Tetrahydrocannabinol on T-Lymphocyte and B-Lymphocyte Mitogen Responses

Klein, T. W., Newton, C. A., Widen, R., & Friedman, H. (1985) · Journal of Immunopharmacology · doi:10.3109/08923978509026487 · Cited by 102 · cited 1× · see citing works

Drugs of abuse and immune function

WATSON, R. R. (1990) · CRC Press eBooks · Cited by 101 · see citing works

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities

BURSTEIN, S. H., Audette, C. A., Breuer, A., Devane, W. A., Colodner, S., Doyle, S. A., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00095a007 · Cited by 99 · see citing works

Dimethylheptyl-THC-11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure

Zurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1 · Cited by 96 · see citing works

Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo

Klein, T., Kawakami, Y., Newton, C. A., & Friedman, H. P. (1991) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399109531496 · Cited by 94 · see citing works

2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells

Kishimoto, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh063 · Cited by 88 · see citing works

Ajulemic acid: A novel cannabinoid produces analgesia without a “high”

BURSTEIN, S. H., Karst, M., Schneider, U., & Zurier, R. B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.010 · Cited by 82 · see citing works

Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes

Kaplan, B. L. F., Rockwell, C. E., & Kaminski, N. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051961 · Cited by 81 · see citing works

Tetrahydrocannabinol inhibition of macrophage nitric oxide production

Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77 · see citing works

Relative involvement of cannabinoid CB1 and CB2 receptors in the Δ9-tetrahydrocannabinol-induced inhibition of natural killer activity

Massi, P., Fuzio, D., Viganò, D., Sacerdote, P., & Parolaro, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00860-2 · Cited by 77 · see citing works

The endocannabinoid signaling system: Pharmacological and therapeutic aspects

Fowler, C. J., Holt, S., Nilsson, O. R., Jonsson, K., Tiger, G., & Jacobsson, S. O. P. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.023 · Cited by 76 · see citing works

delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.

McCoy, K. L., Gainey, D., & Cabral, G. A. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09609-0 · Cited by 74 · cited 3× · see citing works

In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells

Blanchard, D. K., Newton, C. A., Klein, T., Stewart, W. E., & Friedman, H. P. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90020-2 · Cited by 69 · see citing works

Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells

Cabral, G. A., TONEY, D. M., Fischer‐Stenger, K., Harrison, M. P., & Marciano‐Cabral, F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00190-h · Cited by 69 · see citing works

Protection Against Septic Shock and Suppression of Tumor Necrosis Factor α and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid

Gallily, R., Yamin, A., Waksmann, Y., Ovadia, H., Weidenfeld, J., Bar-Joseph, A., Biegon, A. R., Mechoulam, R., & Shohami, E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37086-7 · Cited by 69 · see citing works

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.

Gallily, R., Yamin, A., Waksmann, Y., Ovadia, H., Weidenfeld, J., Bar-Joseph, A., Biegon, A. R., Mechoulam, R., & Shohami, E. (1997) · PubMed · Cited by 67 · see citing works

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1

Stefano, G. B., Bilfinger, T. V., Rialas, C. M., & Deutsch, D. G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0702 · Cited by 64 · see citing works

Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid

Zurier, R. B., Rossetti, R. G., BURSTEIN, S. H., & Bidinger, B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01604-0 · Cited by 62 · see citing works

9-Tetrahydrocannabinol Decreases Alpha/Beta Interferon Response to Herpes Simplex Virus Type 2 in the B6C3F1 Mouse

Cabral, G. A., Lockmuller, J. C., & Mishkin, E. M. (1986) · Experimental Biology and Medicine · doi:10.3181/00379727-181-42258 · Cited by 59 · see citing works

Delta-9-Tetrahydrocannabinol Decreases Host Resistance to Herpes Simplex Virus Type 2 Vaginal Infection in the B6C3F1 Mouse

Mishkin, E. M., & Cabral, G. A. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-12-2539 · Cited by 57 · see citing works

1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.

Dajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M., Dayton, M. T., & Mir, G. (1999) · PubMed · Cited by 57 · see citing works

Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status

Rayman, N., Lam, K. H., Laman, J. D., Simons, P. J., Löwenberg, B., Sonneveld, P., & Delwel, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2111 · Cited by 49 · see citing works

Role of cannabinoid receptors in inhibiting macrophage costimulatory activity

Chuchawankul, S., Shima, M., Buckley, N. E., Hartmann, C. B., & McCoy, K. L. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2003.12.011 · Cited by 48 · see citing works

Differential Inhibition of RAW264.7 Macrophage Tumoricidal Activity by 9Tetrahydrocannabinol

Burnette-Curley, D., & Cabral, G. A. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-210-43926 · Cited by 48 · see citing works

Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae

Cabral, G. A., & Marciano‐Cabral, F. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.027 · Cited by 45 · see citing works

Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus calmétte-guérin-activated macrophages

Burnette-Curley, D., Marciano‐Cabral, F., Fischer‐Stenger, K., & Cabral, G. A. (1993) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(93)90048-4 · Cited by 41 · see citing works

Influence of Marijuana Components (THC and CBD) on Human Mononuclear Cell Cytokine Secretion In vitro

Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_7 · Cited by 39 · see citing works

Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery

Ho, W. ‐. V., & Hiley, C. R. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023682 · Cited by 38 · see citing works

Induction of Interleukin-2 Receptor α Gene by Δ 9 -Tetrahydrocannabinol Is Mediated by Nuclear Factor κB and CB1 Cannabinoid Receptor

Daaka, Y., Zhu, W., Friedman, H., & Klein, T. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.301 · Cited by 38 · see citing works

9-Tetrahydrocannabinol Decreases Cytotoxic T Lymphocyte Activity to Herpes Simplex Virus Type 1-Infected Cells

Fischer‐Stenger, K., Updegrove, A. W., & Cabral, G. A. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43452 · Cited by 36 · see citing works

Delta‐9‐tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators

Cabral, G. A., & Mishkin, E. M. (1989) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398909531243 · Cited by 34 · see citing works

9-Tetrahydrocannabinol Suppresses Macrophage Extrinsic Antiherpesvirus Activity

Cabral, G. A., & Vasquez, R. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-199-43356 · Cited by 34 · see citing works

Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain

Mitchell, V. A., Aslan, S. C., Safaei, R., & Vaughan, C. W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.019 · Cited by 31 · see citing works

Suppression by Cannabinoids of a Cloned Cell Line with Natural Killer Cell Activity

Kawakami, Y., Klein, T., Newton, C., Djeu, J. Y., Dennert, G., Specter, S., & Friedman, H. (1988) · Experimental Biology and Medicine · doi:10.3181/00379727-187-42676 · Cited by 29 · see citing works

Δ9-tetrahydrocannabinol suppresses concanavalin a induced increase in cytoplasmic free calcium in mouse thymocytes

Yebra, M., Klein, T., & Friedman, H. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90009-e · Cited by 27 · see citing works

1′,1′-Dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic Acid: A Novel, Orally Effective Cannabinoid with Analgesic and Anti-inflammatory Properties

Dajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M. S., Dayton, M. T., & Mir, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35067-0 · Cited by 25 · see citing works

Modulation of Interleukin 2 Activity by 9-Tetrahydrocannabinol after Stimulation with Concanavalin A, Phytohemagglutinin, or Anti-CD3 Antibody

Nakano, Y., Pross, S. H., & Friedman, H. P. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-201-43494c · Cited by 24 · see citing works

Resistance to Legionella pneumophila Suppressed by the Marijuana Component, Tetrahydrocannabinol

Klein, T., Newton, C. A., & Friedman, H. P. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.1177-a · Cited by 23 · see citing works

Immunosuppression by Marijuana and Components

Friedman, H. P., Klein, T., & Specter, S. C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-043780-1.50041-5 · Cited by 22 · see citing works

delta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits.

Zhu, W., Igarashi, T., Friedman, H. P., & Klein, T. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10542-9 · Cited by 15 · see citing works

Dimethylheptyl-THC-11-oic Acid

Zurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_49 · Cited by 8 · see citing works

Cannabinoids and the gut: New developments and emerging concepts

Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 421 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Effects of Marijuana Smoking on the Lung

Tashkin, D. P. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201212-127fr · Cited by 298 · see citing works

Probiotics, Prebiotics, and Phytogenic Substances for Optimizing Gut Health in Poultry

Shehata, A. A., Yalçın, S., Latorre, J. D., Basiouni, S., Attia, Y. A., El‐Wahab, A. A., Visscher, C., El-Seedi, H. R., Huber, C., Hafez, H. M., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020395 · Cited by 315 · see citing works

Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells

Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., & Vogel, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069294 · Cited by 286 · see citing works

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.04.001 · Cited by 264 · see citing works

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 256 · see citing works

Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease

O’Sullivan, S. E., & Kendall, D. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 247 · see citing works

Cannabinoids and the immune system: An overview

Tănăsescu, R., & Constantinescu, C. S. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.12.005 · Cited by 243 · see citing works

Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System

Chanda, P. K., Gao, Y., Mark, L., Btesh, J., Strassle, B. W., Lu, P., Piesla, M. J., Zhang, M.-Y., Bingham, B., Uveges, A. J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068304 · Cited by 228 · see citing works

Serum and gene expression profile of cytokines in first-episode psychosis

Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217 · see citing works

Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 205 · see citing works

Clinical applications of hallucinogens: a review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201 · see citing works

Cannabis, the pregnant woman and her child: weeding out the myths

Jaques, S. C., Kingsbury, A. M., Henshcke, P., Chomchai, C., Clews, S., Falconer, J., Abdellatif, M., Feller, J. M., & Oei, J. L. (2014) · Journal of Perinatology · doi:10.1038/jp.2013.180 · Cited by 199 · see citing works

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence

Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 186 · see citing works

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183 · see citing works

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 182 · see citing works

Cannabinoid CB 2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J., & Tuma, R. F. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600447 · Cited by 165 · see citing works

Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

Taha, T., Meiri, D., Talhamy, S., Wollner, M., Peer, A., & Bar‐Sela, G. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0383 · Cited by 157 · see citing works

Cannabinoids and autoimmune diseases: A systematic review

Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 143 · see citing works

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 135 · see citing works

Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation

Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 141 · see citing works

Drugs of Abuse, Immune Modulation, and AIDS

Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9023-5 · Cited by 128 · see citing works

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury

Zhang, M., Adler, M. W., Abood, M. E., Ganea, D., Jallo, J., & Tuma, R. F. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.03.005 · Cited by 124 · see citing works

Neuroprotective agents: Cannabinoids

Sánchez, A., & Garcı́a-Merino, A. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.010 · Cited by 119 · see citing works

The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis

Tschöp, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., Dattilo, J. R., Lentsch, A. B., Tschöp, M. H., & Caldwell, C. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900203 · Cited by 118 · see citing works

Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells

Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 117 · see citing works

Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Ganea, D., & Tuma, R. F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.022 · Cited by 116 · see citing works

Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study

Reece, A. S., Norman, A. F., & Hulse, G. K. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011891 · Cited by 112 · see citing works

Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders

Siniscalco, D., Sapone, A., Giordano, C., Cirillo, A., de Magistris, L., Rossi, F., Fasano, A., Bradstreet, J. J., Maione, S., & Antonucci, N. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1824-9 · Cited by 108 · see citing works

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. J., Kong, W., Ganea, D., & Tuma, R. F. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9148-4 · Cited by 101 · see citing works

Spice/K2 drugs – more than innocent substitutes for marijuana

Zawilska, J. B., & Wojcieszak, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001247 · Cited by 98 · see citing works

The antimicrobial effect behind Cannabis sativa

Schofs, L., Sparo, M. D., & Bruni, S. F. S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.761 · Cited by 102 · see citing works

Opioid Receptors and Signaling on Cells from the Immune System

Bidlack, J. M., Khimich, M., Parkhill, A. L., Sumagin, S., Sun, B., & Tipton, C. M. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9026-2 · Cited by 93 · see citing works

Cannabis smoking and respiratory health: Consideration of the literature

Gates, P., Jaffé, A., & Copeland, J. (2014) · Respirology · doi:10.1111/resp.12298 · Cited by 90 · see citing works

Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells

Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 90 · see citing works

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

Rajasekaran, M., Brents, L. K., Franks, L. N., Moran, J. H., & Prather, P. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.012 · Cited by 90 · see citing works

Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance

Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 88 · see citing works

Immunoregulatory Role of Cannabinoids during Infectious Disease

Hernández‐Cervantes, R., Méndez‐Díaz, M., Prospero-Garcia, O. E., & Morales‐Montor, J. (2017) · NeuroImmunoModulation · doi:10.1159/000481824 · Cited by 86 · see citing works

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 82 · see citing works

Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

Suryavanshi, S. V., Kovalchuk, I., & Kovalchuk, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613613 · Cited by 86 · see citing works

Acute Effects of a Selective Cannabinoid-2 Receptor Agonist on Neuroinflammation in a Model of Traumatic Brain Injury

Elliott, M. B., Tuma, R. F., Amenta, P. S., Barbe, M. F., & Jallo, J. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1672 · Cited by 77 · see citing works

Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain

Britch, S. C., Goodman, A. G., Wiley, J. L., Pondelick, A. M., & Craft, R. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263319 · Cited by 76 · see citing works

The endocannabinoid system modulates stress, emotionality, and inflammation

Crowe, M. S., Nass, S. R., Gabella, K. M., & Kinsey, S. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.007 · Cited by 72 · see citing works

Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection

Lu, T., Newton, C. A., Perkins, I., Friedman, H. P., & Klein, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108381 · Cited by 69 · see citing works

Effects of cannabinoids and their receptors on viral infections

Tahamtan, A., Tavakoli‐Yaraki, M., Rygiel, T. P., Mokhtari‐Azad, T., & Salimi, V. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24292 · Cited by 66 · see citing works

Cannabis for the treatment of Crohn's disease

Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012853.pub2 · Cited by 66 · see citing works

Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier

Vendel, E., & de Lange, E. C. M. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8314-x · Cited by 64 · see citing works

Cannabinoid Receptor 2 (CB2) Mediates Immunoglobulin Class Switching from IgM to IgE in Cultures of Murine-Purified B Lymphocytes

Agudelo, M., Newton, C. A., Widen, R. H., Sherwood, T. A., Nong, L., Friedman, H. P., & Klein, T. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9088-9 · Cited by 63 · see citing works

miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia—Effect of cannabinoids

Juknat, A., Gao, F., Coppola, G., Vogel, Z., & Kozela, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212039 · Cited by 63 · see citing works

CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection

Newton, C. A., Chou, P.-J., Perkins, I., & Klein, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9126-2 · Cited by 62 · see citing works

Toxic effects of prenatal exposure to alcohol, tobacco and other drugs

Scott-Goodwin, A. C., Puerto, M., & Moreno, I. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.03.043 · Cited by 62 · see citing works

Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis

Sainsbury, B., Bloxham, J., Pour, M. H., Padilla, M., & Enciso, R. (2021) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2021.21.6.479 · Cited by 61 · see citing works

Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60 · see citing works

Cannabinoids and Viral Infections

Reiss, C. S. (2010) · Pharmaceuticals · doi:10.3390/ph3061873 · Cited by 59 · see citing works

Indomethacin has a potent antiviral activity against SARS CoV-2 in vitro and canine coronavirus in vivoPreprint

Xu, T., Gao, X., Wu, Z., Selinger, D. W., & Zhou, Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.017624 · Cited by 57 · see citing works

Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9-tetrahydrocannabinol

Buchweitz, J. P., Karmaus, P. W. F., Williams, K. J., Harkema, J. R., & Kaminski, N. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907618 · Cited by 55 · see citing works

Cannabis for the treatment of Crohn's disease

Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012853 · Cited by 53 · see citing works

Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010

Alshaarawy, O., & Anthony, J. C. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.017 · Cited by 51 · see citing works

Therapeutic Potential of Cannabinoid-Based Drugs

Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49 · see citing works

Cannabis for the treatment of ulcerative colitis

Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012954.pub2 · Cited by 47 · see citing works

Cannabinoids as therapeutics for PTSD

Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47 · see citing works

Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes

Castaneda, J. T., Harui, A., Kiertscher, S. M., Roth, J. D., & Roth, M. D. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9430-8 · Cited by 47 · see citing works

Pure Δ 9 -tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ 9 -tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages

Romano, B., Pagano, E., Orlando, P., Capasso, R., Cascio, M. G., Pertwee, R. G., Marzo, V. D., Izzo, A. A., & Borrelli, F. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.045 · Cited by 46 · see citing works

Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience

Mostafavi, M., & Gaitanis, J. N. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100833 · Cited by 52 · see citing works

Cannabis-derived cannabidiol and nanoselenium improve gut barrier function and affect bacterial enzyme activity in chickens subjected to C. perfringens challenge

Konieczka, P., Szkopek, D., Kinsner, M., Fotschki, B., Juśkiewicz, J., & Banach, J. (2020) · Veterinary Research · doi:10.1186/s13567-020-00863-0 · Cited by 44 · see citing works

The Immune Endocannabinoid System of the Tumor Microenvironment

Kienzl, M., Kargl, J., & Schicho, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238929 · Cited by 44 · see citing works

Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program

Reece, A. S. (2007) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-2-35 · Cited by 43 · see citing works

The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases

Argenziano, M., Tortora, C., Bellini, G., Paola, A. D., Punzo, F., & Rossi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235875 · Cited by 43 · see citing works

Determinants of pulse wave velocity trajectories from youth to young adulthood

Liang, X., Su, S., Hao, G., Snieder, H., Treiber, F. A., Kapuku, G. K., & Wang, X. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001933 · Cited by 42 · see citing works

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB1/CB2 receptors

Braun, A., Engel, T., Aguilar‐Pimentel, J. A., Zimmer, A., Jakob, T., Behrendt, H., & Mempel, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.09.004 · Cited by 41 · see citing works

European medicinal and edible plants associated with subacute and chronic toxicity part II: Plants with hepato-, neuro-, nephro- and immunotoxic effects

Kristanc, L., & Kreft, S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.014 · Cited by 37 · see citing works

Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders

Omeragic, A., Kayode, O., Hoque, M. T., & Bendayan, R. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00204-5 · Cited by 37 · see citing works

Cannabinoids and the Microbiota–Gut–Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders

Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37 · see citing works

Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells

Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 35 · see citing works

Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1

Yndart, A., Kolishetti, N., Vashist, A., Madepalli, L., Llaguno, L., & Nair, M. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-32927-4 · Cited by 34 · see citing works

CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Hu, S., Sheng, W. S., & Rock, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077577 · Cited by 34 · see citing works

The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects

Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 33 · see citing works

Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation

Osafo, N., Yeboah, K. O., & Antwi, A. O. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06366-1 · Cited by 31 · see citing works

Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation

Roth, M. D., Castaneda, J. T., & Kiertscher, S. M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9587-z · Cited by 31 · see citing works

Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease

Strisciuglio, C., Bellini, G., Miele, E., Martinelli, M., Cenni, S., Tortora, C., Tolone, C., del Giudice, E. M., & Rossi, F. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000755 · Cited by 29 · see citing works

Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation

Castaneda, J. T., Harui, A., & Roth, M. D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9744-7 · Cited by 27 · see citing works

No significant effect of cannabis use on the count and percentage of circulating CD4 T‐cells in HIV‐HCV co‐infected patients (ANRS CO13‐HEPAVIH French cohort)

Marcellin, F., Lions, C., Rosenthal, É., Roux, P., Sogni, P., Wittkop, L., Protopopescu, C., Spire, B., Salmon, D., Dabis, F., et al. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12398 · Cited by 26 · see citing works

Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles

Williams, J., Klein, T., Goldberger, B. A., Sleasman, J. W., Mackman, N., & Goodenow, M. M. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0084-1 · Cited by 25 · see citing works

Anandamide prior to sensitization increases cell-mediated immunity in mice

Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Sakai, M., Costa‐Pinto, F. A., & Palermo‐Neto, J. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.017 · Cited by 25 · see citing works

Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence

Sexton, M. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0144 · Cited by 24 · see citing works

Effect of Cannabis sativa on oxidative stress and organ damage after systemic endotoxin administration in mice

Abdel‐Salam, O. M. E., Nada, S. A., Salem, N. A., El-Shamarka, M. E.-S., & Omara, E. A. A. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1745-1 · Cited by 24 · see citing works

Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity

Gibson, C. L., Nia, A. B., Spriggs, S. A., DeFrancisco, D., Swift, A., Perkel, C., Zhong, X., Mazumdar, M., Fernandez, N., Patel, M., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113380 · Cited by 22 · see citing works

Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage

Tan, Q., Chen, Q., Feng, Z., Shi, X., Tang, J., Tao, Y., Jiang, B., Tan, L., Feng, H., Zhu, G., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.10.016 · Cited by 22 · see citing works

Cannabinoids and the Cannabinoid Receptors: An Overview

Lu, D., & Potter, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00068-5 · Cited by 23 · see citing works

The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas

Wasik, A. M., Christensson, B., & Sander, B. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.004 · Cited by 21 · see citing works

Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review

Zielińska, A., Eder, P., Karczewski, J., Szalata, M., Hryhorowicz, S., Wielgus, K., Szalata, M., Dobrowolska, A., Atanasov, A. G., Słomski, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147991 · Cited by 21 · see citing works

Δ9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood

Moretti, S., Castelli, M., Franchi, S., Raggi, M. A., Mercolini, L., Protti, M., Somaini, L., Panerai, A. E., & Sacerdote, P. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0713-406rr · Cited by 20 · see citing works

Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis

Sexton, M., Silvestroni, A., Möller, T., & Stella, N. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0133-9 · Cited by 20 · see citing works

Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer

Cherkasova, V., Kovalchuk, O., & Kovalchuk, I. (2021) · Cancers · doi:10.3390/cancers13174353 · Cited by 19 · see citing works

Exposure to morphine affects the expression of endocannabinoid receptors and immune functions

Zhang, Q., Zhang, M., & Cao, Y. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.04.003 · Cited by 19 · see citing works

Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock

Lafreniere, J. D., & Lehmann, C. (2017) · Metabolites · doi:10.3390/metabo7040055 · Cited by 19 · see citing works

Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews

Riera, R., Pacheco, R. L., Bagattini, Â. M., & Martimbianco, A. L. C. (2021) · Phytotherapy Research · doi:10.1002/ptr.7263 · Cited by 19 · see citing works

Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine

Jin, L., Pan, L., Guo, Y., Zheng, Y., Nie, Z., & Zhu, R. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1994 · Cited by 19 · see citing works

Clinical implications of addiction related immunosuppression

Reece, A. S. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.03.003 · Cited by 19 · see citing works

Cannabis and Immune Homeostasis: A Critical Narrative Review of the Molecular Mechanisms Underlying Cannabinoid-Induced Immunomodulation

Rathore, S. S., Amit, A., Yadav, M., Kashyap, D., & Uikey, B. N. (2026) · Journal of Disease and Global Health · doi:10.56557/jodagh/2026/v19i210913

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.04.001 · Cited by 264 · see citing works

Cannabinoids as Novel Anti-Inflammatory Drugs

Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555 · see citing works

Effects of Cannabinoids on the Immune System and Central Nervous System

Molina‐Holgado, E., Guaza, C., Borrell, J. I., & Molina‐Holgado, F. (1999) · BioDrugs · doi:10.2165/00063030-199912050-00001 · Cited by 22 · see citing works

Review article Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?

Croxford, J. L., & Yamamura, T. (2005)